Animal angiography testing is a specialized preclinical imaging service that visualizes and quantifies blood vessels in laboratory animals using contrast-enhanced techniques such as micro-CT, digital subtraction angiography (DSA), and MR angiography. It supports vascular disease modeling, medical device evaluation, and drug efficacy studies by delivering precise morphological and functional data on the vasculature. This article explains the technical principles, sample types, testing items, analytical methods, and common questions related to animal angiography detection.
Technical Overview
Animal angiography testing refers to the systematic imaging, detection, and quantitative analysis of blood vessels in laboratory animals or excised animal tissues. By administering a contrast agent into the vascular system—either intravascularly in vivo or by perfusion in ex vivo specimens—vessel architecture, lumen geometry, patency, and perfusion can be visualized at resolutions ranging from whole-body macrovasculature down to capillary-level networks. This testing is a cornerstone of preclinical cardiovascular research, providing objective endpoints for evaluating vascular disease models, therapeutic angiogenesis, restenosis, aneurysm progression, and the in vivo performance of vascular implants such as stents, grafts, and occlusion devices.
Modern animal angiography integrates multiple complementary modalities. Contrast-enhanced micro-CT offers micron-scale three-dimensional visualization of vascular casts and perfused specimens, while digital subtraction angiography enables real-time, serial in vivo assessment of large- and medium-caliber vessels. Magnetic resonance angiography supports longitudinal studies without ionizing radiation, and optical techniques such as fluorescein or indocyanine green angiography, laser Doppler imaging, and optical coherence tomography provide functional information on microvascular perfusion. Testing programs are typically conducted in accredited third-party laboratories under GLP-compliant quality systems, with animal protocols reviewed by institutional animal care and ethics committees and study design aligned with ARRIVE reporting guidelines.
Testing Samples
Small Laboratory Animals
Mice and rats are the most common subjects for vascular imaging due to the availability of transgenic disease models and well-characterized surgical procedures. Typical applications include hindlimb ischemia models for therapeutic angiogenesis assessment, carotid artery injury models for restenosis research, aortic aneurysm models, and tumor vascularization studies. Both in vivo imaging and post-mortem vascular casting approaches are supported for these species.
Large Laboratory Animals
Rabbits, minipigs, canines, and sheep are used when larger vessel diameters or human-like hemodynamic and anatomical conditions are required, particularly for the evaluation of stents, stent grafts, embolic agents, and vascular access devices. DSA and contrast-enhanced CT are the primary modalities for these species, often performed in interventional suites replicating clinical catheterization workflows.
Ex Vivo Vascular Specimens
Excised aortas, carotid arteries, femoral arteries, hindlimb vascular beds, and tumor-bearing tissues can be perfused with contrast agents or polymer casting compounds prior to imaging. Ex vivo preparation eliminates motion artifacts and permits high-resolution micro-CT scanning with isotropic voxel sizes at the micrometer level, making it ideal for quantitative vascular network analysis.
Vascular Casts and Device-Implanted Specimens
Corrosion casts produced by polymer perfusion provide permanent three-dimensional replicas of complete vascular trees. Specimens containing implanted stents, covered grafts, or coils can also be imaged to assess apposition, luminal coverage, in-stent restenosis, and endothelialization status.
Testing Items
Animal angiography testing programs typically cover the following analytical endpoints, tailored to the study objectives and the selected imaging modality:
- Vascular morphology and three-dimensional architecture, including branching pattern, tortuosity, and vessel course
- Lumen diameter, cross-sectional area, and vessel wall dimensions at defined anatomical landmarks
- Stenosis or occlusion grading, including percent lumen narrowing and minimal lumen area
- Quantification of neovascularization, capillary density, and angiographic collateral score in ischemic models
- Perfusion assessment, blood flow velocity, and time-to-peak enhancement measurements
- Aneurysm sac dimension, neck geometry, and endoleak detection following device intervention
- Vascular volume, total vessel length, and branching point counts derived from micro-CT datasets
- In-stent patency, apposition, and intimal hyperplasia evaluation for vascular implants
- Tumor vascular density, permeability, and response to anti-angiogenic therapy
- Longitudinal comparison of serial scans to track disease progression or treatment effect
Testing Methods
Contrast-Enhanced Micro-CT Angiography: Specimens are perfused with iodinated or barium-based contrast media, or non-sulfur polymer casting materials, and scanned at high spatial resolution. Resulting datasets are reconstructed in three dimensions and analyzed with semi-automated segmentation software to extract vascular volume, density, and geometry parameters.
Digital Subtraction Angiography (DSA): Under anesthesia, a catheter is introduced via a femoral or carotid access route and a bolus of iodinated contrast is injected while fluoroscopic images are acquired. Pre-contrast masks are subtracted to isolate the vascular signal, enabling real-time assessment of vessel patency, flow dynamics, and interventional device deployment.
Magnetic Resonance Angiography (MRA): Non-contrast time-of-flight techniques or gadolinium-enhanced protocols visualize vessels without ionizing radiation, supporting repeated longitudinal measurements in the same animals across multiple time points.
Contrast-Enhanced Ultrasound: Microbubble contrast agents enable functional evaluation of microvascular perfusion and can quantify blood volume and flow in targeted organs or tumors.
Optical and Fluorescence Angiography: Intravenous fluorescent tracers such as fluorescein isothiocyanate-dextran, Evans blue dye, or indocyanine green allow visualization of microvasculature and vascular permeability; laser Doppler and laser speckle imaging map superficial tissue perfusion in ischemia models.
Corrosion Casting: A low-viscosity resin is perfused through the vasculature, followed by dissolution of surrounding tissue, yielding a physical cast for scanning electron microscopy or micro-CT examination of microvascular architecture.
Image Analysis and Quantification: Acquired datasets are processed with validated software for vessel segmentation, centerline extraction, morphometric measurement, and statistical comparison between experimental groups, with reporting compliant with the study protocol and applicable quality system requirements.
Applications
Animal angiography testing serves a broad range of preclinical and translational research applications:
- Characterization and validation of vascular disease models, including atherosclerosis, aneurysm, ischemia, and diabetes-related vascular complications
- Preclinical safety and performance evaluation of vascular implants in accordance with ISO 10993 biocompatibility principles and device-specific guidance such as ISO 25539 series considerations for endovascular prostheses
- Efficacy assessment of pro-angiogenic or anti-angiogenic therapeutics, including growth factors, gene therapies, and small molecules
- Pharmacological studies of vasoactive compounds, thrombosis inhibitors, and restenosis-preventing drugs
- Tumor angiogenesis research and anti-vascular treatment response monitoring
- Tissue engineering research, including vascularization of scaffolds and regenerative constructs
- Comparative anatomy and educational three-dimensional vascular atlas development
- Publication support, regulatory submission packages, and verification of genetically modified animal phenotypes
FAQ
Question: What animal species are suitable for angiography testing?
Answer: Mice and rats are most widely used for disease modeling and drug studies, while rabbits, minipigs, canines, and sheep are preferred for vascular device evaluation because their vessel sizes more closely resemble human anatomy. Ex vivo tissues from any of these species can be analyzed by casting and micro-CT methods.
Question: Can in vivo and ex vivo angiography be combined in one study?
Answer: Yes. A common design performs serial in vivo DSA, MRA, or ultrasound imaging at defined follow-up points, followed by terminal ex vivo micro-CT casting for high-resolution endpoint analysis. This combination maximizes longitudinal data and terminal anatomical detail.
Question: What spatial resolution can be achieved?
Answer: Micro-CT angiography of vascular casts typically achieves isotropic voxel sizes from tens of micrometers down to sub-micrometer levels depending on sample size and scanner configuration. Clinical DSA resolves vessels in the sub-millimeter range and is suited to macrovascular assessment.
Question: How is animal welfare ensured during in vivo imaging?
Answer: All procedures are reviewed and approved by the institutional animal care and use committee. Anesthesia, physiological monitoring, analgesia, contrast agent dosing, and euthanasia follow established veterinary care standards and applicable national regulations governing laboratory animal use.
Question: What information should be provided when commissioning a study?
Answer: Sponsors should provide the animal model description, study objective, target vascular bed, preferred imaging modality, time points, sample size, and any protocol requirements. The testing laboratory will then confirm feasibility, propose an imaging and analysis plan, and provide a timeline and deliverables including reconstructed images, quantitative data tables, and a study report.
Question: What is the typical turnaround time?
Answer: Turnaround depends on study complexity. Simple ex vivo casting and scanning projects may be completed within one to three weeks, whereas longitudinal in vivo studies with multiple imaging sessions and full quantitative analysis may extend over several weeks or months according to the protocol schedule.